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a b s t r a c t 
We present the case of a 50-year-old female who underwent bilateral ovarian artery em- 
bolization for uterine fibroids in the setting of hypoplastic uterine arteries. Ovarian artery 
embolization is usually conducted during uterine artery embolization for fibroids to increase 
the procedure success when ovarian feeders are seen. The bilateral ovarian artery emboliza- 
tion is rarely performed due to fears of amenorrhea and early menopause from decreased 
blood supply to both ovaries. According to our knowledge, this the first case report describ- 
ing primary bilateral ovarian artery embolization in the setting of a rare anatomic variant- 
hypoplastic uterine arteries. The patient had complete resolution of symptoms from her 
uterine fibroids after treatment with bilateral ovarian artery embolization with no ovarian 
failure findings on the follow-up. 
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
Introduction 
Uterine artery embolization is an established therapy for the 
management of symptomatic uterine fibroids. While the pro- 
cedure reduces total leiomyoma volume and decreases or 
eliminates clinical symptoms, the procedure’s failure rate 
stands at 9.4% [ [1] ]. One cause of treatment failure is persistent 
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blood supply to the fibroid from utero-ovarian anastomosis 
branches. Although various studies have described success- 
ful unilateral ovarian artery embolization for the treatment of 
symptomatic uterine fibroids, to the best of our knowledge, 
primary bilateral ovarian artery embolization (BOAE) in the 
setting of hypoplastic uterine arteries has not been described 
in the literature. In this report, we aim to illustrate the tech- 
nical feasibility and outcome of a patient with the rare vari- 
ant of hypoplastic uterine arteries treated with BOAE and for 
https://doi.org/10.1016/j.radcr.2021.05.069 
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Fig. 1 – (A) Pre-embolization sagittal T1 weighted (W) Fat-Saturated (FS) post-contrast image through the pelvis demonstrates 
numerous intramural (black arrows) and subserosal (white arrow) enhancing fibroids. (B) Post-embolization sagittal T1-W 
FS post-contrast image through the pelvis demonstrates multiple intramural non-enhancing treated fibroids (black arrows). 
symptomatic uterine fibroids. Case reports are exempt from 
institutional review board approval at the originating institu- 
tion. 
Case report 
A 50-year-old woman with a 16-year history of menorrhagia, 
dysmenorrhea, and anemia secondary to uterine fibroids pre- 
sented to our multidisciplinary fibroid clinic. Upon evaluat- 
ing clinical and MRI (magnetic resonance imaging) findings 
( Fig. 1 A), we discussed medical, interventional, and surgical 
options with the patient and the gynecologist, and a decision 
was made to perform uterine fibroid embolization (UFE). In- 
formed consent was obtained for the procedure. Initial pelvic 
aortogram demonstrated bilateral hypertrophic ovarian arter- 
ies feeding the enlarged fibromatous uterus. Bilateral uterine 
arteries were diminutive on the angiogram. ( Fig. 2 ). Endovas- 
cular embolization of both ovarian arteries was performed 
with 500 to 700 microns and 700 to 900 microns of Embosphere 
microspheres (Merit Medical Systems, Inc, South Jordan, Utah) 
using a 2.4-French Progreat microcatheter (Terumo Medical 
Corporation, Somerset, New Jersey) through a 4-French (F) 
Mickelson catheter (Cook, Inc, Bloomington, Indiana) until 
near stasis. 
At the six-week clinic follow-up, no early complications 
were observed, and the patient was satisfied with the pro- 
cedure. MRI was obtained as part of the six-month follow- 
up, which showed decreased uterine and fibroids size with no 
residual fibroid enhancement ( Fig. 1 B). During the six-month 
clinic visit, she reported having regular periods for three cy- 
cles with no pelvic pain and heavy bleeding. She denied ovar- 
ian failure symptoms. On the MRI, both ovaries revealed no 
evidence of infarction. The pre-procedure hemoglobin level of 
4.5 g/dL increased to 11.9 g/dL. At 9-months, she decided to 
have a hysterectomy due to a fibroid expulsion and desire not 
to have menstruations anymore. The gynecologist performed 
total laparoscopic hysterectomy and salpingo-oophorectomy. 
Histopathologic assessment of the post-surgical specimen 
demonstrated embolization material within blood vessels ad- 
jacent to a leiomyoma with ischemic-type necrosis consistent 
with embolization ( Fig. 3 ). 
Discussion 
Bilateral OAE is rarely discussed in the literature to treat uter- 
ine fibroids with collateral supply from the ovarian artery. One 
fear clinicians have in performing bilateral OAE is ovarian fail- 
ure resulting from infarction. There is also conflicting liter- 
ature with Razavi et al., concluding that ovarian artery em- 
bolization should only be performed unilaterally [ 2 ]. On the 
contrary, a case series by Barth et al. noted that three patients 
treated with bilateral OAE in addition to uterine artery em- 
bolization retained ovarian function after the procedure [ 3 ]. In 
this report, bilateral OAE did not cause early menopause after 
the procedure while still achieving complete clinical success. 
There are two case reports in the literature describing bi- 
lateral hypoplastic/absent uterine artery variant which was 
found during uterine artery embolization attempt. In these 
cases, embolization was not performed due to fear of caus- 
ing early menopause. In our case, we decided to perform the 
embolization despite the rare variant anatomy due to patient 
long history of anemia and initial decision to avoid hysterec- 
tomy [ 4 ]. 
From a technical standpoint, 500 to 700 microns and 700 to 
900 microns Embospheres proved to be adequate in achiev- 
ing near stasis of blood flow during bilateral ovarian artery 
embolization. It was further confirmed after histologic stain- 
ing, which showed embolization material within one of the 
fibroids. Despite embolic material seen in the ovary on his- 
tology ( Fig. 3 B), the patient did not exhibit any ovarian failure 
symptoms after the procedure. MRI and histopathology find- 
ings supported that both ovaries were still viable. One may de- 
duce from this report that the same-sized Embospheres typi- 
cally used for uterine artery embolizations can also be used in 
bilateral ovarian artery embolizations. However, Verret et al. 
reported that either 700 or 900-micron Embozene (CeloNova 
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Fig. 2 – (A) Digital subtraction aortogram demonstrates enlarged tortuous ovarian arteries (white arrows) and hypoplastic 
uterine arteries (black arrows). (B) Delayed phase image from digital subtraction aortogram shows opacification of the 
fibromatous uterus (black arrows). 
Fig. 3 – (A) Histopathologic images of the embolized uterine 
fibroid. Original magnification x4. Hematoxylin and eosin. 
Embolization material (black arrows) within the arteries 
adjacent to a leiomyoma with ischemic-type necrosis 
(white arrow). (B) Original magnification x4. Hematoxylin 
and eosin. Embolization material (arrows) within the hilum 
of the ovary. 
Biosciences, Newnan, Georgia) occluded significantly more 
distally than 700 to 900 micron Embospheres in sheep mod- 
els. However, this report indicates that 700 to 900 micron Em- 
bospheres can adequately embolize the distal blood flow to 
the fibromatous uterus without compromising ovarian func- 
tion [ 5 ]. 
In conclusion, fibromatous uterus with bilateral primary 
blood supply from the ovarian arteries can be considered 
for bilateral ovarian artery embolization in selected patients. 
Long term follow-up will be needed to establish long term 
safety. 
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